Machine Learning

A new solar + storage project in Texas uses advanced AI to maximize value and bolster the grid, setting a new standard for renewable operations in ERCOT.

With major retail deals at Walmart and Costco, AXIL aims to convince investors its hearing tech, not just haircare, can deliver profitable growth.

A new partnership aims to use light and AI to break bottlenecks in drug development, promising to make personalized medicine faster and more accessible.

With experience at Chelsea FC and New Zealand Rugby, Andrea Magini brings a new data-centric model of athlete recovery to the highest levels of sport.

As the RV market soars, roadsurfer hosts nationwide events to lure new travelers. Is it a friendly invite or a strategic play to dominate the road?

As its stock stumbles, web-game leader CTW heads to the Roth Conference to prove its unique anime IP and HTML5 model can deliver long-term growth.

After solving a key manufacturing flaw, CervoMed advances its promising dementia drug, neflamapimod, to a Phase 3 trial with an optimized dose.

NelsonHall recognizes LTM as a leader in banking AI, signaling a major industry shift from experimentation to scalable, enterprise-wide implementation.

Amesite's NurseMagic™ is a finalist for a top nursing award, validating its strategy to cut paperwork and capture a slice of the post-acute care pie.

A massive $125M investment empowers five international teams to pursue radical ideas, from cancer-proof people to self-destructing tumors.

The popular transit app now uses AI to learn your travel habits, offering custom routes and tradeoff summaries. But what is the cost of this convenience?

Theolytics secures a prestigious €8 million EU grant to advance its unique cancer-killing virus, offering new hope for hard-to-treat ovarian cancer.

A new patented drug, budiodarone, aims to treat atrial fibrillation in heart failure patients, a group with few safe options. Is this the future of care?

Tired of huge roaming bills and hunting for SIM cards? A new partnership promises a seamless, automated eSIM experience for millions of travelers.

With four new partners and a zero-markup model, Harrison.ai's Open Platform aims to democratize access to powerful medical AI tools for providers globally.

A new partnership at MWC 2026 aims to revolutionize train safety with a unified hybrid 5G network that promises unbreakable, always-on connectivity.

ClassLink's new Insights platform aims to prove the ROI of digital tools by linking usage data to test results, a potential game-changer for school budgets.

Immunome announces stellar Phase 3 data for its desmoid tumor drug, varegacestat, and details a robust, well-funded ADC pipeline aimed at solid tumors.

The nation's leading aesthetic provider launches a Salmon DNA Facial, XTherma, and NAD+ injections, betting on the science of regenerative beauty.

A new exclusive partnership between lens giant ZEISS and MEC aims to arm independent practices with advanced tech and operational might. But what does it mean?